Ypsomed Investing $195M Into Holly Springs, NC Drug Manufacturing Facility

Ypsomed announced plans Oct. 9 to invest $195.4M in Holly Springs for its first North American manufacturing facility. The company will purchase and customize an existing 110,000-square-foot building in the YIELD Holly Springs. This purpose-built manufacturing campus is part of the broader Holly Springs Business Park, located just off N.C. 55. Ypsomed has committed to creating 62 high-quality jobs.

“This announcement brings an expansion in the life science offerings in Holly Springs, diversifying the types of companies located here,” said Holly Springs Mayor Sean Mayefskie. “Everyone knows about the global biotech leaders who call Holly Springs home, and Ypsomed will provide needed medical device supplies to contribute to the creation of life-saving medications these companies will produce right here in Holly Springs.”

Ypsomed is a Switzerland-based medical device company that celebrated its 40th anniversary in 2024. The company is known as a global leader in injection and infusion systems for self-medication, particularly for diabetes care; Ypsomed partners with top pharmaceutical and biotech companies for innovative delivery systems such as pens, autoinjectors, and pumps.

“Ypsomed’s decision to locate in Holly Springs reinforces our community as a strategic location for advanced manufacturing and life sciences,” said Holly Springs Economic Development Director Irena Krstanovic.

Krstanovic noted that the project helps support the Town’s long-term fiscal sustainability by reducing reliance on residential property taxes. The company plans to make its investment in Holly Springs over the next 5 years.